MANNINO RAPHAEL J 4
4 · Matinas BioPharma Holdings, Inc. · Filed Sep 14, 2021
Insider Transaction Report
Form 4
MANNINO RAPHAEL J
Chief Scientific Officer
Transactions
- Other
Common Stock, par value $0.0001 per share
2021-09-03+462,150→ 1,919,715 total
Footnotes (1)
- [F1]Shares received pursuant to an amendment to the Agreement and Plan of Merger dated as of January 29, 2015 by an among the Issuer, Saffron Merger Sub, Inc. and Aquarius Biotechnologies Inc.